Clinical Trial Update: A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) [EARLY_Phase 1]

View source ↗

Summary

This document provides an update on Janssen's Phase 1 trial to identify biomarker signatures for early detection of pulmonary hypertension, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Pulmonary Hypertension

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Hypertension, Pulmonary | EARLY_Phase 1 | Status: COMPLETED